Cyclopropanes

Results: 865



#Item
41ViiV Healthcare Receives EU marketing authorization for Triumeq®, a Single-pill Regimen Containing the Integrase Inhibitor “Dolutegravir” Osaka, Japan, September 4, Shionogi & Co., Ltd. (Head Office: Osaka; P

ViiV Healthcare Receives EU marketing authorization for Triumeq®, a Single-pill Regimen Containing the Integrase Inhibitor “Dolutegravir” Osaka, Japan, September 4, Shionogi & Co., Ltd. (Head Office: Osaka; P

Add to Reading List

Source URL: shionogi616.tew-staging.com

Language: English - Date: 2015-01-27 14:49:56
42What is the Hottest New Molecule in RCC? (excluding targeted immunotherapeutics) Emiliano Calvo, MD PhD START Madrid, Centro Integral

What is the Hottest New Molecule in RCC? (excluding targeted immunotherapeutics) Emiliano Calvo, MD PhD START Madrid, Centro Integral

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2014-05-13 15:09:11
43Microsoft Word - NDASafyral 10Apr12.doc

Microsoft Word - NDASafyral 10Apr12.doc

Add to Reading List

Source URL: labeling.bayerhealthcare.com

Language: English - Date: 2012-04-10 22:40:02
44Shionogi-ViiV Healthcare Starts Phase III Trial for “572-Trii” Fixed-Dose Combination HIV Therapy London, UK, 3 February 2011 – Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the c

Shionogi-ViiV Healthcare Starts Phase III Trial for “572-Trii” Fixed-Dose Combination HIV Therapy London, UK, 3 February 2011 – Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the c

Add to Reading List

Source URL: shionogi616.tew-staging.com

Language: English - Date: 2014-11-03 11:26:17
45Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV London, United Kingdom, 11 July 2012: Shionogi-ViiV Healthcare LLC today announced that initia

Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV London, United Kingdom, 11 July 2012: Shionogi-ViiV Healthcare LLC today announced that initia

Add to Reading List

Source URL: shionogi616.tew-staging.com

Language: English - Date: 2014-11-03 11:26:18
46Let’s Go PO Transitional Antimicrobial Therapy Benefits of Oral Therapy  Equally effective as IV  Shortened Length of Stay  Fewer Bacteremias

Let’s Go PO Transitional Antimicrobial Therapy Benefits of Oral Therapy  Equally effective as IV  Shortened Length of Stay  Fewer Bacteremias

Add to Reading List

Source URL: ugotabug.med.miami.edu

Language: English - Date: 2011-09-27 12:30:10
47Cert ID(SA) Phys  THE COLLEGES OF MEDICINE OF SOUTH AFRICA Incorporated Association not for gain Reg No

Cert ID(SA) Phys THE COLLEGES OF MEDICINE OF SOUTH AFRICA Incorporated Association not for gain Reg No

Add to Reading List

Source URL: www.fidssa.co.za

Language: English - Date: 2013-10-01 01:34:06
48A Complete List of Genes, Binary Decoding Tapes, and Decimal Codes of the 1882 LSBF that Can be Realized via a CNN of Four Input Variables FANGYUE CHEN  ∗

A Complete List of Genes, Binary Decoding Tapes, and Decimal Codes of the 1882 LSBF that Can be Realized via a CNN of Four Input Variables FANGYUE CHEN ∗

Add to Reading List

Source URL: www.ee.cityu.edu.hk

Language: English - Date: 2006-03-27 01:31:49
49

PDF Document

Add to Reading List

Source URL: www.lymepa.org

Language: English - Date: 2014-07-19 16:37:34
50QADCorrespondence AIDS 2006, 20:000–000  Concerns regarding a randomized trial of two postexposure prophylaxis regimens

QADCorrespondence AIDS 2006, 20:000–000 Concerns regarding a randomized trial of two postexposure prophylaxis regimens

Add to Reading List

Source URL: files.figshare.com

Language: English - Date: 2015-03-13 09:13:57